Skip to content

    Concord Drugs Limited

    Overview

    Price

    Market Cap

    ₹107 Cr

    Sector

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly

    Balance Sheet

    Balance Sheet

    ₹ Cr · Annual
    Line itemFY22FY23FY24FY25FY26FY26
    LiabilitiesEquity Capital9910101013
    Reserves202224242435
    Borrowings161718191714
    Other Liabilities12107121713
    Total Liabilities565859656975
    AssetsFixed Assets141312121212
    CWIP112222
    Investments011111
    Other Assets424445505460
    Total Assets565859656975

    Cash Flow

    Cash Flow

    ₹ Cr · Annual
    Line itemFY22FY23FY24FY25FY26
    ActivitiesCash from Operating1214-7
    Cash from Investing-2-2-1-2-1
    Cash from Financing210-18
    SummaryCapital Expenditure
    Free Cash Flow-21-01-8
    FCF Margin

    Valuation

    Cyclical, with too little history

    This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.

    CONCORD · CYCLICAL_UNMODELABLE

    Learn to analyse Concord Drugs Limited

    Guides on how to read this kind of business and the numbers that matter.